Cargando…
Cross-variant proof predictive vaccine design based on SARS-CoV-2 spike protein using immunoinformatics approach
BACKGROUND: Coronavirus Disease (COVID-19) is caused by the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2). The SARS-CoV-2 virus is evolving continuously. The omicron variant of SARS-CoV-2 has the highest mutation in its spike protein, thus making the presently available vaccine ineffe...
Autores principales: | Sahu, Lavanya Kumar, Singh, Kiran |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9831375/ https://www.ncbi.nlm.nih.gov/pubmed/36644779 http://dx.doi.org/10.1186/s43088-023-00341-4 |
Ejemplares similares
-
Immunoinformatics Study: Multi-Epitope Based Vaccine Design from SARS-CoV-2 Spike Glycoprotein
por: Umitaibatin, Ramadhita, et al.
Publicado: (2023) -
Vaccine design of coronavirus spike (S) glycoprotein in chicken: immunoinformatics and computational approaches
por: Awadelkareem, Eman A., et al.
Publicado: (2020) -
Identification of vaccine candidate against Omicron variant of SARS-CoV-2 using immunoinformatic approaches
por: Aasim, et al.
Publicado: (2022) -
Multi-Epitope Vaccine Design Using an Immunoinformatic Approach for SARS-CoV-2
por: Feng, Ye, et al.
Publicado: (2021) -
Design of a Recombinant Multivalent Epitope Vaccine Based on SARS-CoV-2 and Its Variants in Immunoinformatics Approaches
por: Yu, Mingkai, et al.
Publicado: (2022)